The SSR, along with 14 other medical organizations, issued a statement of agreement regarding the benefits of hormone therapy for symptomatic menopausal women.

• Bailar J. Retrospective: hormone-replacement therapy and cardiovascular diseases. N Engl J Med 2003; 349(6):521-522.
• Herrington DM, Howard TD. From presumed benefit to potential harm—hormone therapy and heart disease. N Engl J Med 2003; 349(6):519-521.
• Hodis HN, Mack WJ, Azen SP, Lobo RA, Shoupe D, Mahrer PR, Faxon DP, Cashin-Hemphill L, Sanmarco ME, French WJ, Shook TL, Gaarder TD, et al. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med 2003; 349(6):535-545.
• Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349(6):523-534.
• Stuenkel CA, Gass MLS, Manson JE, Lobo RA, Pal L, Rebar RW, Hall JE. A decade after the Women’s Health Initiative—the experts do agree. Fertil Steril 2012; 98(2).